若年関連タンパク質が老化脳の免疫細胞機能を回復 (Youth-Associated Protein Helps Restore Healthy Function in Immune Cells in the Aging Brain)

ad

2026-08-14 マウントサイナイ医療システム(MSHS)

米マウントサイナイ医科大学の研究チームは、若年個体で豊富に存在する特定タンパク質が、加齢によって機能低下した脳内免疫細胞を若返らせ、健全な脳機能の回復を促進することを明らかにした。研究では、脳の主要な免疫細胞であるミクログリアに着目し、老化に伴う慢性炎症や異常な免疫応答が神経変性や認知機能低下に関与する仕組みを解析した。その結果、「若年関連タンパク質」を投与すると、老化したミクログリアの炎症性状態が改善され、細胞の代謝機能や老廃物除去能力が回復することが判明した。さらに、アルツハイマー病などの神経変性疾患に関連する病理学的変化も軽減され、脳内環境の正常化が認められた。この成果は、老化そのものを標的とする新たな治療戦略の可能性を示すものであり、単なる症状緩和ではなく、加齢に伴う免疫機能低下の根本改善につながる可能性がある。研究チームは今後、ヒトへの応用可能性を検証し、認知症や加齢関連神経疾患の予防・治療法開発を進めるとしている。

若年関連タンパク質が老化脳の免疫細胞機能を回復 (Youth-Associated Protein Helps Restore Healthy Function in Immune Cells in the Aging Brain)
Image reconstruction of microglia from an aged mouse treated with TIMP2 showing synaptic material (purple) within the cell’s lysosomes (green). Credit: Mount Sinai Health System

<関連情報>

若年期関連タンパク質TIMP2は、健康なマウスと高齢マウスにおけるミクログリアの状態と機能を調節する Youth-associated protein TIMP2 regulates microglial state and function in healthy and aged mice

Brittany M. Hemmer,Sarah M. Philippi,Ana Catarina Ferreira,Samuele F. Petridis,Annie Phan & Joseph M. Castellano
Nature Communications  Published:12 August 2026
DOI:https://doi.org/10.1038/s41467-026-74906-z

Abstract

There is little understanding of how aging serves as the strongest risk factor for several neurodegenerative diseases. Microglia undergo age-related maladaptive changes, including increased inflammation, impaired debris clearance, and cellular senescence, yet specific mediators that regulate these processes remain unclear. The aged brain is rejuvenated by youth-associated plasma factors, including tissue inhibitor of metalloproteinases 2 (TIMP2), which we have shown acts on the extracellular matrix (ECM) to regulate synaptic plasticity. Given emerging roles for microglia in these processes, we examined the impact of TIMP2 on microglial function. We show that TIMP2 deletion in mice exacerbates microglial phenotypes associated with aging, including transcriptomic changes in cell activation, changes in lysosomal-associated markers and phagocytosis, and elevated levels of stress and inflammatory proteins in the brain extracellular space measured by in vivo microdialysis. Deleting specific cellular pools of TIMP2 in vivo increases microglial CD68 and alters myelin phagocytosis. Treating aged mice with TIMP2 reverses several phenotypes observed in our deletion models, resulting in decreased microglial activation, reduced proportions of proinflammatory microglia, and enhanced phagocytosis of physiological substrates. Our results identify TIMP2 as a modulator of age-associated microglia dysfunction. Harnessing its activity may mitigate detrimental effects of age-associated insults on microglia function.

医療・健康
ad
ad
Follow
ad
タイトルとURLをコピーしました